Pfizer/BioNTech Covid-19 vaccine highly protective in 12-18 age group: US CDC study
The Pfizer/BioNTech vaccine is authorised for children as young as 12, and the companies are seeking authorisation for use in those as young as five years of age.Reuters WASHINGTON - The Pfizer/BioNTech Covid-19 vaccine was 93 per cent effective in preventing hospitalisations among those aged 12 to 18, according to an analysis released by the US Centres...